Brokerages Set agilon health, inc. (NYSE:AGL) Target Price at $4.79

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) have been assigned a consensus recommendation of "Hold" from the nineteen ratings firms that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and five have issued a buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $4.79.

Several equities research analysts have recently weighed in on AGL shares. Sanford C. Bernstein upgraded shares of agilon health from a "market perform" rating to an "outperform" rating and increased their price objective for the stock from $3.30 to $8.50 in a research report on Tuesday, April 8th. TD Cowen increased their price objective on shares of agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th. JMP Securities reiterated a "market perform" rating on shares of agilon health in a research report on Monday, April 28th. Cowen restated a "hold" rating on shares of agilon health in a report on Tuesday, April 15th. Finally, Stifel Nicolaus raised their price target on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a report on Wednesday, February 26th.

Institutional Trading of agilon health

Several hedge funds have recently added to or reduced their stakes in AGL. Ieq Capital LLC bought a new stake in agilon health in the fourth quarter worth about $26,000. Signaturefd LLC raised its position in shares of agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares during the period. Humankind Investments LLC bought a new stake in shares of agilon health in the fourth quarter valued at approximately $30,000. Raymond James Financial Inc. bought a new stake in shares of agilon health in the fourth quarter valued at approximately $33,000. Finally, Cerity Partners LLC bought a new stake in shares of agilon health in the fourth quarter valued at approximately $34,000.

agilon health Trading Down 4.9%

Shares of AGL stock traded down $0.12 during trading hours on Friday, hitting $2.24. 5,382,205 shares of the company's stock traded hands, compared to its average volume of 4,960,961. The stock's 50 day simple moving average is $3.83 and its 200 day simple moving average is $3.17. The stock has a market cap of $925.18 million, a PE ratio of -2.38 and a beta of 0.38. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same period in the prior year, the company posted ($0.02) earnings per share. agilon health's revenue for the quarter was down 4.5% compared to the same quarter last year. On average, sell-side analysts anticipate that agilon health will post -0.59 EPS for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.